Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$466M |
| 2 |
Applovin
APP
|
+$349M |
| 3 |
General Dynamics
GD
|
+$272M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$257M |
| 5 |
iShares Global Infrastructure ETF
IGF
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$396M |
| 2 |
HES
Hess
HES
|
+$383M |
| 3 |
Apple
AAPL
|
+$362M |
| 4 |
NVIDIA
NVDA
|
+$298M |
| 5 |
Microsoft
MSFT
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.46% |
| 2 | Financials | 12.23% |
| 3 | Consumer Discretionary | 9.45% |
| 4 | Communication Services | 8.8% |
| 5 | Healthcare | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Tronox
TROX
$909M
| $4.24M | ﹤0.01% |
1,054,663
-2,920
| -0.3% | -$13.4K |
|
|
ORKA
2602
Oruka Therapeutics
ORKA
$5.72B
| $4.23M | ﹤0.01% |
219,709
-2,469
| -1% | -$36.6K |
|
2603
Inter&Co
INTR
$2.49B
| $4.22M | ﹤0.01% |
457,136
-14,462
| -3% | -$114K |
|
2604
Phathom Pharmaceuticals
PHAT
$726M
| $4.21M | ﹤0.01% |
357,578
-1,746
| -0.5% | -$18K |
|
2605
Telefônica Brasil
VIV
$20.3B
| $4.2M | ﹤0.01% |
329,336
+9,028
| +3% | +$108K |
|
2606
Lightbridge
LTBR
$283M
| $4.19M | ﹤0.01% |
197,759
+14,503
| +8% | +$218K |
|
2607
Establishment Labs
ESTA
$2.73B
| $4.19M | ﹤0.01% |
102,214
-5,703
| -5% | -$233K |
|
2608
Idaho Strategic Resources
IDR
$461M
| $4.19M | ﹤0.01% |
123,935
-5,275
| -4% | -$125K |
|
2609
Miller Industries
MLR
$572M
| $4.19M | ﹤0.01% |
103,598
+755
| +0.7% | +$31.8K |
|
2610
Zevra Therapeutics
ZVRA
$594M
| $4.18M | ﹤0.01% |
439,480
+14,361
| +3% | +$144K |
|
2611
Solid Power
SLDP
$479M
| $4.17M | ﹤0.01% |
1,202,199
+87,231
| +8% | +$329K |
|
2612
Spok Holdings
SPOK
$232M
| $4.16M | ﹤0.01% |
240,986
-2,017
| -0.8% | -$35.9K |
|
2613
Marcus Corp
MCS
$946M
| $4.15M | ﹤0.01% |
267,615
+46,103
| +21% | +$739K |
|
2614
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
| $4.15M | ﹤0.01% |
69,117
+10,606
| +18% | +$633K |
|
2615
Banco Santander Chile
BSAC
$16.4B
| $4.15M | ﹤0.01% |
156,425
+3,591
| +2% | +$88.1K |
|
2616
Community Health Systems
CYH
$412M
| $4.14M | ﹤0.01% |
1,290,957
+7,282
| +0.6% | +$21.9K |
|
2617
Schwab US Large-Cap Growth ETF
SCHG
$61.2B
| $4.14M | ﹤0.01% |
129,687
+12,474
| +11% | +$380K |
|
|
XRN
2618
Chiron Real Estate Inc
XRN
$467M
| $4.14M | ﹤0.01% |
122,711
+1,827
| +2% | +$65K |
|
|
HDSN
2619
Hudson Technologies
HDSN
$262M
| $4.14M | ﹤0.01% |
416,507
-13,271
| -3% | -$125K |
|
|
BCAX
2620
Bicara Therapeutics
BCAX
$1.69B
| $4.12M | ﹤0.01% |
260,866
+29,253
| +13% | +$327K |
|
|
MOFG
2621
DELISTED
MidWestOne Financial Group
MOFG
| $4.11M | ﹤0.01% |
145,203
-17,275
| -11% | -$504K |
|
2622
Tonix Pharmaceuticals
TNXP
$170M
| $4.1M | ﹤0.01% |
169,687
+5,665
| +3% | +$210K |
|
2623
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $4.08M | ﹤0.01% |
41,746
-4,194
| -9% | -$389K |
|
2624
Rush Enterprises Class B
RUSHB
$6.1B
| $4.07M | ﹤0.01% |
70,857
-3,270
| -4% | -$184K |
|
2625
Hercules Capital
HTGC
$3.15B
| $4.07M | ﹤0.01% |
215,039
+91,687
| +74% | +$1.76M |
|
Similar funds
Northern Trust's Q3 2025 Portfolio in Review
As of Q3 2025, Northern Trust held 4,566 positions worth $782B, up 7.5% from $727B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Northern Trust's Q3 2025 filing shows 167 new, 1,770 increased, 2,268 reduced and 144 closed positions. Its largest new stake was Amrize Ltd: 1,020,799 shares worth $49.5M. The largest sale was Ansys, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Northern Trust's largest Q3 2025 buy was Amrize Ltd: 1,020,799 shares worth $49.5M.
- Northern Trust added most to Chevron in Q3 2025, an estimated $466M increase.
- Northern Trust's biggest Q3 2025 reduction was Apple, cutting an estimated $362M.
- Northern Trust fully exited Ansys in Q3 2025, selling an estimated $396M.
- Northern Trust's ten largest holdings make up 30% of its $782B portfolio in Q3 2025.
- Northern Trust opened 167 new positions and closed 144 in Q3 2025.
- Northern Trust's portfolio value rose 7.5% quarter-over-quarter to $782B.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.